Molecular and Translational Neuroscience

Molecular and Translational Neuroscience (MTN) is a medical-related master's degree at the uulm and offers a degree in research-oriented neuroscience with a view to its clinical applications.

MTN is a research-oriented master's program that offers students a highly qualified education in the field of basic research as well as clinical and therapeutic-oriented neuroscience. The aim of molecular and translational neuroscience is to improve the diagnosis and therapy of neurological and psychiatric diseases. Neurological and psychiatric diseases are, for example, multiple sclerosis, meningitis, stroke, depression, schizophrenia and ADS/ADHD or typical neurological diseases of old age such as dementia and Parkinson's. They cause massive limitations in the quality of life of the patients, sometimes even to the point of completely losing their ability to lead an independent life.

Existing therapy methods are often not sufficiently effective because the underlying pathomechanisms have not yet been clarified. Therefore, translational neuroscience has set itself the task of investigating physiological and pathophysiological mechanisms in the adaptation and homeostasis of the nervous system.

Molecular neurobiological questions have a bridging function between cellular and pharmacological basic research, molecular neurology, behavioral physiology and diagnostic and pharmacological application. The results are implemented in precise approaches to innovative therapies and prophylaxis.